Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Botulinum Toxin-A Injection on Facial Wrinkles, Appearance, and Psychosocial Outcomes
ChiCTR2200061373Phase 4Recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in rhytides, sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Overall Facial Satisfaction, Expectations for the Surgery and 5 more. Started Jun 2022; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on ChiCTR2200061373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061373.